|
RAB7L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.59829999996286E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.54889999999642E-05 |
| Normal-vs-Stage2 |
5.799300E-03 |
| Normal-vs-Stage3 |
1.456130E-02 |
| Normal-vs-Stage4 |
1.17889999995402E-06 |
| Stage1-vs-Stage2 |
6.262200E-01 |
| Stage1-vs-Stage3 |
4.354200E-01 |
| Stage1-vs-Stage4 |
8.980500E-02 |
| Stage2-vs-Stage3 |
8.574800E-01 |
| Stage2-vs-Stage4 |
1.021420E-01 |
| Stage3-vs-Stage4 |
9.550200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19819999999205E-05 |
| Normal-vs-AfricanAmerican |
2.24139999999151E-05 |
| Normal-vs-Asian |
5.825400E-01 |
| Caucasian-vs-AfricanAmerican |
2.808600E-01 |
| Caucasian-vs-Asian |
7.208400E-01 |
| AfricanAmerican-vs-Asian |
6.001000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.46889999996791E-06 |
| Normal-vs-Female |
8.200000E-04 |
| Male-vs-Female |
4.514200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.183780E-03 |
| Normal-vs-Extreme_Weight |
1.3881999999521E-06 |
| Normal-vs-Obese |
1.237050E-03 |
| Normal-vs-Extreme_Obese |
6.385800E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.919200E-01 |
| Normal_Weight-vs-Obese |
5.885400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.727600E-01 |
| Extreme_Weight-vs-Obese |
1.023200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.338440E-01 |
| Obese-vs-Extreme_Obese |
7.612400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.10240000000561E-05 |
| Normal-vs-Age(41-60Yrs) |
8.47830000000327E-05 |
| Normal-vs-Age(61-80Yrs) |
2.10219999999817E-05 |
| Normal-vs-Age(81-100Yrs) |
2.467500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.645210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.735800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.333800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.738200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.693800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.933600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.98869999995721E-06 |
| Normal-VS-Type2 PRCC |
1.057990E-01 |
| Normal-VS-KIRP CIMP |
2.04209999998817E-06 |
| Normal-VS-Unclassified PRCC |
3.800300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.619900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.084800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.768600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.356400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.886200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.521500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.401100E-03 |
| Normal-vs-N1 |
6.49259999999652E-05 |
| Normal-vs-N2 |
2.104200E-01 |
| N0-vs-N1 |
1.747570E-01 |
| N0-vs-N2 |
9.915000E-01 |
| N1-vs-N2 |
4.574600E-01 |
|
|
